Aldeyra Therapeutics

ALDX

Sector
Healthcare

Industry
Biotechnology

Website
aldeyra.com




Buy / Sell (dollars)

1 Month

100% 100% Complete (success)
0% 0% Complete (danger)
$99,915.79
avg. $99,915.79
$0.00
avg. $0.00

Buy/Sell Ratio

0

Transactions

2

Filers

1

3 Month

100% 100% Complete (success)
0% 0% Complete (danger)
$691,514.66
avg. $230,504.89
$0.00
avg. $0.00

Buy/Sell Ratio

0

Transactions

17

Filers

7

12 Month

41.7% 41.7% Complete (success)
58.3% 58.3% Complete (danger)
$691,514.66
avg. $57,626.22
$968,397.43
avg. $80,699.79

Buy/Sell Ratio

0.714

Transactions

22

Filers

10

24 Month

41.7% 41.7% Complete (success)
58.3% 58.3% Complete (danger)
$691,514.66
avg. $28,813.11
$968,397.43
avg. $40,349.89

Buy/Sell Ratio

0.714

Transactions

22

Filers

10

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers